What were Sanofi India Ltd's latest quarterly results?
Sanofi India Ltd's latest quarterly results (Dec 2024) show
- PAT Growth YoY: -34.1%
- Revenue Growth YoY: +9.8%
- Operating Margin: 23.0%
Sanofi India Ltd: Stock Analysis & Fundamentals
Updated this weekSanofi India Ltd (Pharma - MNC bulk Drugs) — fundamental analysis, earnings data, and key metrics. PE: 16.6. ROE: 47.1%. This stock is not currently in the Nifty 500 momentum outperformers list.
Key Numbers
Current Price
₹3,191
Dividend Yield
3.67%
Market Cap
7.3K Cr
Valuation
N/AOther Top Pharma - MNC bulk Drugs Stocks Beating Nifty 500
Frequently Asked Questions: Sanofi India Ltd
Based on publicly available financial data. This is educational research, not investment advice.
What is Sanofi India Ltd's current PE ratio?
Sanofi India Ltd's current PE ratio is 16.6x.
- Current PE: 16.6x
- Market Cap: 7.3K Cr
- Dividend Yield: 3.67%
What is Sanofi India Ltd's price-to-book ratio?
Sanofi India Ltd's price-to-book ratio is 8.5x.
- Price-to-Book (P/B): 8.5x
- Book Value per Share: ₹374
- Current Price: ₹3191
Is Sanofi India Ltd a fundamentally strong company?
Sanofi India Ltd's fundamental strength based on key financial ratios
- Return on Capital (ROCE): 49.0%
Is Sanofi India Ltd debt free?
Sanofi India Ltd has a debt-to-equity ratio of N/A.
- Total Debt: ₹19 Cr
What is Sanofi India Ltd's return on equity (ROE) and ROCE?
Sanofi India Ltd's return ratios over recent years
- Dec 2024: ROCE 49.0%
Is Sanofi India Ltd's cash flow positive?
Sanofi India Ltd's operating cash flow is positive (Dec 2024).
- Cash from Operations (CFO): ₹462 Cr
- Free Cash Flow (FCF): ₹282 Cr
- CFO/PAT Ratio: 112% (strong cash conversion)
What is Sanofi India Ltd's dividend yield?
Sanofi India Ltd's current dividend yield is 3.67%.
- Dividend Yield: 3.67%
- Current Price: ₹3191
Who holds Sanofi India Ltd shares — promoters, FII, DII?
Sanofi India Ltd's shareholding pattern (Dec 2025)
- Promoters: 60.4%
- FII (Foreign): 5.5%
- DII (Domestic): 21.3%
- Public: 12.8%
Is promoter holding increasing or decreasing in Sanofi India Ltd?
Sanofi India Ltd's promoter holding has remained stable recently.
- Current Promoter Holding: 60.4% (Dec 2025)
- Previous Quarter: 60.4% (Sep 2025)
- Change: 0.00% (stable)
Is Sanofi India Ltd a new momentum entry or an established outperformer?
Sanofi India Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.
Is Sanofi India Ltd worth studying for long term investment?
Based on quantitative research signals, here is why Sanofi India Ltd may be worth studying
- Cash flow is positive — CFO ₹462 Cr
What is the investment thesis for Sanofi India Ltd?
Sanofi India Ltd investment thesis summary:
What is the future outlook for Sanofi India Ltd?
Sanofi India Ltd's forward outlook based on current data signals
- Insufficient data for a forward assessment — monitoring for more signals
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.